Family Quality of Life Among Families With a Member Who is a Cancer Patient
This study has been completed.
Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborator:
Information provided by (Responsible Party):
Barbara Murphy, MD, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT00544336
First received: October 13, 2007
Last updated: September 7, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Developing a questionnaire that can be used to assess the quality of life among people who have a family member with cancer may help the study of cancer in the future.
PURPOSE: This clinical trial is studying quality of life among families with a member who is a cancer patient.
| Condition | Intervention |
|---|---|
|
Breast Cancer Colorectal Cancer Head and Neck Cancer Lung Cancer Prostate Cancer Solid Tumor |
Other: questionnaire administration Other: survey administration Procedure: quality-of-life assessment |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Assessment of Family Quality of Life Among Families With a Member Who is a Cancer Patient |
Resource links provided by NLM:
Genetics Home Reference related topics:
breast cancer
MedlinePlus related topics:
Benign Tumors
Breast Cancer
Cancer
Colorectal Cancer
Head and Neck Cancer
Lung Cancer
Prostate Cancer
Tonsils and Adenoids
U.S. FDA Resources
Further study details as provided by Vanderbilt-Ingram Cancer Center:
Primary Outcome Measures:
- Preliminary validation of a family quality of life questionnaire [ Time Frame: Off study date ] [ Designated as safety issue: No ]
- Generation of an initial item pool (step 1) [ Time Frame: Off study date ] [ Designated as safety issue: No ]
- Reduction of the item pool based on content validity assessment (step 2) [ Time Frame: Off study date ] [ Designated as safety issue: No ]
- Psychometric properties and dimensionality of the measure (step 3) [ Time Frame: Off study date ] [ Designated as safety issue: No ]
| Enrollment: | 366 |
| Study Start Date: | August 2007 |
| Study Completion Date: | May 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Supportive |
Other: questionnaire administration
no intervention
Other Name: questionnaire administration
Other: survey administration
no intervention
Other Name: survey administration
Procedure: quality-of-life assessment
no intervention
Other Name: quality-of-life assessment
|
Detailed Description:
OBJECTIVES:
- Develop and conduct preliminary validation of a Family Quality of Life Questionnaire for use with families with an adult cancer patient, with the measure appropriate for use for both research and clinical assessment purposes.
- Generate an initial item pool for the measure (step 1).
- Reduce the item pool based on a content validity assessment (step 2).
- Assess the psychometric properties and dimensionality of the measure (step 3).
OUTLINE:
- Step 1 (item generation): Items are generated through a literature review and a semi-structured interview with patients and their families. The purposes of the interview are to determine whether the five domains identified in the literature review (family interaction, family roles, family communication, family emotional support, overall family quality of life [FQOL]) are central areas of FQOL, and to determine if there are other important FQOL domains affected by cancer and its treatment. Patients and their family members are interviewed individually over 45-60 minutes. The initial item pool is generated based on the literature review and interviews.
- Step 2 (item review and reduction): The initial item pool is examined and reduced based on its content validity. Ten health care providers with a minimum of five years experience working with cancer patients rate the content validity of the proposed questionnaire. Experts receive a packet of questionnaires, including the objective of the study, the proposed questionnaire as developed in step 1, and the proposed questionnaire with its format modified for the examination of content validity. The content validity version uses a 4-point Likert format to assess each item's relevance, sufficiency (i.e., the extent to which it fully covers its intended domain) and clarity in relation to the construct (FQOL domain) that it is supposed to assess. Experts are asked to rate the overall format of the questionnaire in regards to ease of use and appropriateness, and for open-ended comments or suggestions. Items are modified or dropped based on the experts' review.
- Step 3 (final item selection and psychometric evaluation): Patients and family members complete the FQOL questionnaire developed in previous steps and other questionnaires with proven reliability and validity at baseline. Other questionnaires include the SF-36 (general QOL survey that is used widely in general population samples and patients, including cancer patients), the FACT-G for patients (instrument used to assess health-related QOL in cancer patients), with the version of the FACT-G modified by Northouse for the family member, the Family Interaction and Emotional Well-Being subscales (to examine family interaction and family emotional support of cancer families) of the Beach Center Family Quality of Life Scale (FQOL measure for families with a disabled child), the Balanced Cohesion subscale (to examine family interaction of cancer families) of the FACES IV (that assesses balanced and unbalanced family cohesion and family flexibility in general population), and the Family Communication Scale (a general survey used to assess family communication in the general population). Patients and family members complete the FQOL again 2 weeks after the initial assessment.
PROJECTED ACCRUAL: Approximately 210 cancer patients and 210 family members will be accrued for this study.
Eligibility| Ages Eligible for Study: | 21 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
Family members of a patient with cancer
Criteria
Inclusion Criteria:
Patients diagnosed with any local, advanced, or metastatic cancer that has required more than a simple surgical procedure
- Ten families with an adult patient with breast, prostate, lung, colon, or head and neck cancer are interviewed for step 1 portion of the study
An available adult family member willing to participate in the study
- The term family is defined broadly to include adults over 21 years of age, considered by the cancer patient as a family member, who provides care or support and/or shares the cancer experience with the patient
- Family members do not need to be biologically related to the patient or related through marriage, and may or may not live in the same house with the patient
Exclusion Criteria:
- Able to read, write, and speak English
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00544336
Locations
| United States, Tennessee | |
| Vanderbilt-Ingram Cancer Center - Cool Springs | |
| Nashville, Tennessee, United States, 37064 | |
| Vanderbilt-Ingram Cancer Center at Franklin | |
| Nashville, Tennessee, United States, 37064 | |
| Vanderbilt-Ingram Cancer Center | |
| Nashville, Tennessee, United States, 37232-6838 | |
Sponsors and Collaborators
Vanderbilt-Ingram Cancer Center
Investigators
| Principal Investigator: | Barbara Murphy, MD | Vanderbilt-Ingram Cancer Center |
More Information
No publications provided
| Responsible Party: | Barbara Murphy, MD, Professor of Medicine; Director, Cancer Supportive Care Program; Director, Head and Neck Research Program; Medical Oncologist, Vanderbilt-Ingram Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00544336 History of Changes |
| Other Study ID Numbers: | VICC SUPP 0737, VU-VICC-SUPP-0737, VU-VICC-IRB-IRB-070598 |
| Study First Received: | October 13, 2007 |
| Last Updated: | September 7, 2012 |
| Health Authority: | United States: Vanderbilt University Human Research Protection Program |
Keywords provided by Vanderbilt-Ingram Cancer Center:
|
unspecified adult solid tumor, protocol specific recurrent breast cancer stage I breast cancer stage II breast cancer stage IIIA breast cancer stage IIIB breast cancer stage IIIC breast cancer stage IV breast cancer recurrent prostate cancer stage I prostate cancer stage II prostate cancer stage III prostate cancer stage IV prostate cancer extensive stage small cell lung cancer limited stage small cell lung cancer |
recurrent non-small cell lung cancer recurrent small cell lung cancer stage I non-small cell lung cancer stage II non-small cell lung cancer stage IIIA non-small cell lung cancer stage IIIB non-small cell lung cancer stage IV non-small cell lung cancer recurrent colon cancer stage I colon cancer stage II colon cancer stage III colon cancer stage IV colon cancer recurrent squamous cell carcinoma of the hypopharynx stage I squamous cell carcinoma of the hypopharynx stage II squamous cell carcinoma of the hypopharynx |
Additional relevant MeSH terms:
|
Breast Neoplasms Colorectal Neoplasms Head and Neck Neoplasms Lung Neoplasms Prostatic Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Digestive System Diseases |
Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Prostatic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013